Our previous studies demonstrate that STAT3 signaling is the critical molecular target of resveratrol although other signaling pathways are inhibited concurrently in resveratrol-treated medulloblastoma cells [19,20,21]. This evidence concerns the gene STAT3 and medulloblastoma.